ReviewPharmacotherapy2015

Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat.

Salma Afifi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.